Dynamic factors controlling targeting nanocarriers to vascular endothelium

Current Drug Metabolism

Volumn 13, Issue 1, 2012, Pages 70-81

  Muzykantov, Vladimir R ^a,b   Radhakrishnan, Ravi ^c   Eckmann, David M ^b,c  

^a University of Pennsylvania   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibody surface density; Carrier concentration; Cell adhesion molecules; Endothelium; Hydrodynamics; Nanocarriers; Optimization; Targeted drug delivery

Indexed keywords

ACTIN; CD31 ANTIGEN; DENDRIMER; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; INTERCELLULAR ADHESION MOLECULE 1; LIPID EMULSION; LIPOSOME; MACROGOL; NANOCARRIER; NANOPARTICLE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PHOSPHOLIPID; SPHINGOMYELIN; THROMBOMODULIN;

ANTIBODY AFFINITY; BINDING AFFINITY; BLOOD FLOW; CELL SURFACE; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; GLYCOCALYX; HUMAN; HYDRODYNAMICS; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; OSMOTIC STRESS; PARTICLE SIZE; PHAGOCYTOSIS; REVIEW; VASCULAR ENDOTHELIUM;

EID: 84857617949     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012798356916     Document Type: Review

References (149)

1. Discher, D.E.; Eisenberg, A. Polymer vesicles. Science, 2002, 297(5583), 967-973. (Pubitemid 34856022)
2. Muzykantov, V.R. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium. Expert Opin. Drug Del., 2005, 2, 909-926. (Pubitemid 41488849)
3. Dziubla, T.D.; Shuvaev, V.V.; Hong, N.K.; Hawkins, B.J.; Madesh, M.; Takano, H.; Simone, E.; Nakada, M.T.; Fisher, A.; Albelda, S.M.; Muzykantov, V.R. Endothelial targeting of semipermeable polymer nanocarriers for enzyme therapies. Biomaterials, 2008, 29(2), 215-227. (Pubitemid 350017841)
4. Dziubla, T.D.; Muzykantov, V.R. Synthetic carriers for vascular delivery of protein therapeutics. Biotechnol. Genet. Eng. Rev, 2006, 22 267-298.
5. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm., 2002, 233(1-2), 51-59. (Pubitemid 34230418)
6. Muro, S.; Schuchman, E.H.; Muzykantov, V.R. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation-and clathrin-dependent endocytosis. Mol. Ther., 2006, 13(1), 135-141. (Pubitemid 41763491)
7. Muzykantov, V.R. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology, 1998, 5(1), 15-33. (Pubitemid 28419502)
8. Kabanov, A.V.; Batrakova, E.V.; Alakhov, V.Y. Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery. J. Controlled Release, 2002, 82(2-3), 189-212. (Pubitemid 34880178)
9. Klibanov, A.L. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjug. Chem. , 2005, 16(1), 9-17. (Pubitemid 40129671)
10. Danilov, S.M.; Gavrilyuk, V.D.; Franke, F.E.; Pauls, K.; Harshaw, D.W.; McDonald, T.D.; Miletich, D.J.; Muzykantov, V.R. Lung uptake of antibodies to endothelial antigens: Key determinants of vascular immunotargeting. Am. J. Physiol. Heart. Circ. Physiol., 2001, 280(6), L1335-L1347.
11. Ding, B.S.; Dziubla, T.; Shuvaev, V.V.; Muro, S.; Muzykantov, V.R. Advanced drug delivery systems that target the vascular endothelium. Mol. Interv., 2006, 6(2), 98-112.
12. Molema, G. Tumor vasculature directed drug targeting: Applying new technologies and knowledge to the development of clinically relevant therapies. Pharm. Res., 2002, 19(9), 1251-1258.
13. Fan, Y.X.; Wong, L.; Deb, T.B.; Johnson, G.R. Ligand regulates epidermal growth factor receptor kinase specificity: Activation in creases preference for GAB1 and SHC versus autophosphorylation sites. J. Biol. Chem., 2004, 279(37), 38143-38150. (Pubitemid 39295960)
14. Eniola, A.O.; Krasik, E.F.; Smith, L.A.; Song, G.; Hammer, D.A. Idomain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. Biophys. J., 2005, 89(5), 3577-3588. (Pubitemid 41636110)
15. Torchilin, V.P. Drug targeting. Eur. J. Pharm. Sci., 2000, 11 Suppl 2 S81-91.
16. Cines, D.B.; Pollak, E.S.; Buck, C.A.; Loscalzo, J.; Zimmerman, G.A.; McEver, R.P.; Pober, J.S.; Wick, T.M.; Konkle, B.A.; Schwartz, B.S.; Barnathan, E.S.; McCrae, K.R.; Hug, B.A.; Schmidt, A.M.; Stern, D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 1998, 91(10), 3527-3561. (Pubitemid 28225719)
17. Gimbrone, M.A., Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol., 1999, 155(1), 1-5.
18. Simionescu, M.; Gafencu, A.; Antohe, F. Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey. Microsc. Res. Tech., 2002, 57(5), 269-288. (Pubitemid 34579213)
19. Vanhoutte, P.M. Endothelium-derived free radicals: For worse and for better. J. Clin. Invest., 2001, 107(1), 23-25. (Pubitemid 32047408)
20. Cybulsky, M.I.; Gimbrone, M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 1991, 251(4995), 788-791.
21. Muro, S.; Gajewski, C.; Koval, M.; Muzykantov, V.R. ICAM-1 recycling in endothelial cells: A novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood, 2005, 105(2), 650-658. (Pubitemid 40070749)
22. Muro, S.; Dziubla, T.; Qiu, W.; Leferovich, J.; Cui, X.; Berk, E.; Muzykantov, V.R. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J. Pharmacol. Exp. Ther., 2006, 317(3), 1161-1169. (Pubitemid 43764121)
23. Muro, S.; Garnacho, C.; Champion, J.A.; Leferovich, J.; Gajewski, C.; Schuchman, E.H.; Mitragotri, S.; Muzykantov, V.R. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther., 2008, 16(8), 1450-1458.
24. Calderon, A.J.; Muzykantov, V.; Muro, S.; Eckmann, D.M. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. Biorheology, 2009, 46(4), 323-341.
25. Garnacho, C.; Dhami, R.; Simone, E.; Dziubla, T.; Leferovich, J.; Schuchman, E.H.; Muzykantov, V.; Muro, S. Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J. Pharmacol. Exp. Ther., 2008, 325(2), 400-408. (Pubitemid 351574785)
26. Murciano, J.C.; Muro, S.; Koniaris, L.; Christofidou-Solomidou, M.; Harshaw, D.W.; Albelda, S.M.; Granger, D.N.; Cines, D.B.; Muzykantov, V.R. ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood, 2003, 101(10), 3977-3984. (Pubitemid 36857875)
27. Eniola, A.O.; Hammer, D.A. Artificial polymeric cells for targeted drug delivery. J. Controlled Release, 2003, 87(1-3), 15-22. (Pubitemid 36255444)
28. Eniola, A.O.; Willcox, P.J.; Hammer, D.A. Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys. J., 2003, 85(4), 2720-2731. (Pubitemid 37210818)
29. Sakhalkar, H.S.; Dalal, M.K.; Salem, A.K.; Ansari, R.; Fu, J.; Kiani, M.F.; Kurjiaka, D.T.; Hanes, J.; Shakesheff, K.M.; Goetz, D.J. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc. Natl. Acad. Sci. USA., 2003, 100(26), 15895-15900. (Pubitemid 38021086)
30. Decuzzi, P.; Ferrari, M. Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials, 2008, 29(3), 377-384. (Pubitemid 350081047)
31. Becker, B.F.; Chappell, D.; Bruegger, D.; Annecke, T.; Jacob, M. Therapeutic strategies targeting the endothelial glycocalyx: Acute deficits, but great potential. Cardiovasc. Res., 2010, 87(2), 300-310.
32. Chittasupho, C.; Xie, S.X.; Baoum, A.; Yakovleva, T.; Siahaan, T.J.; Berkland, C.J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci., 2009, 37(2), 141-150.
33. Reitsma, S.; Slaaf, D.W.; Vink, H.; van Zandvoort, M.A.M.J.; Egbrink, M.G.A.O. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch., 2007, 454(3), 345-359. (Pubitemid 46742429)
34. Spragg, D.D.; Alford, D.R.; Greferath, R.; Larsen, C.E.; Lee, K.D.; Gurtner, G.C.; Cybulsky, M.I.; Tosi, P.F.; Nicolau, C.; Gimbrone, M.A., Jr. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system. Proc. Natl. Acad. Sci. USA, 1997, 94(16), 8795-8800. (Pubitemid 27335119)
35. Batrakova, E.V.; Kabanov, A.V. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Controlled Release, 2008, 130(2), 98-106.
36. Calderon, A.J.; Bhowmick, T.; Leferovich, J.; Burman, B.; Pichette, B.; Muzykantov, V.R.; Eckmann, D.M.; Muro, S. Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J. Controlled Release, 2011, 150 37-44.
37. Champion, J.A.; Katare, Y.K.; Mitragotri, S. Particle shape: A new design parameter for micro-and nanoscale drug delivery carriers. J. Controlled Release, 2007, 121(1-2), 3-9. (Pubitemid 47126059)
38. Charoenphol, P.; Huang, R.B.; Eniola-Adefeso, O. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials, 2010, 31(6), 1392-1402.
39. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol., 2007, 2(4), 249-255. (Pubitemid 46739812)
40. Simone, E.A.; Dziubla, T.D.; Colon-Gonzalez, F.; Discher, D.E.; Muzykantov, V.R. Effect of polymer amphiphilicity on loading of a therapeutic enzyme onto protective fulamentous and spherical polymer nanocarrlers. Biomacromolecules, 2007, 8(12), 3914-3921.
41. Torchilin, V.P. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur. J. Pharm. Biopharm., 2009, 71(3), 431-444.
42. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev., 2001, 53(2), 283-318. (Pubitemid 32476118)
43. Haun, J.B.; Hammer, D.A. Quantifying nanoparticle adhesion mediated by specific molecular interactions. Langmuir, 2008, 24(16), 8821-8832.
44. Hossen, N.; Kajimoto, K.; Akita, H.; Hyodo, M.; Ishitsuka, T.; Harashima, H. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J. Controlled Release, 2010, 147(2), 261-268.
45. Shmeeda, H.; Tzernach, D.; Mak, L.; Gabizon, A. Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage. J. Controlled Release, 2009, 136(2), 155-160.
46. Torchilin, V.P.; Levchenko, T.S.; Lukyanov, A.N.; Khaw, B.A.; Klibanov, A.L.; Rammohan, R.; Samokhin, G.P.; Whiteman, K.R. p-Nitrophenylcarbonyl-PEG-PE- liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim. Biophys. Acta, 2001, 1511(2), 397-411. (Pubitemid 32250227)
47. D'Aquino, R.; Harper, T.; Vas, C.R. Nanobiotechnology -Fulfilling the promise of nanomedicine. Chem. Eng. Progr., 2006, 102(2), 35-37.
48. Khademhosseini, A.; Langer, R. Nanobiotechnology -Drug delivery and tissue engineering. Chem. Eng. Progr., 2006, 102(2), 38-42.
49. Bakowsky, H.; Richter, T.; Kneuer, C.; Hoekstra, D.; Rothe, U.; Bendas, G.; Ehrhardt, C.; Bakowsky, U. Adhesion characteristics and stability assessment of lectin-modified liposomes for sitespecific drug delivery. Biochim. Biophys. Acta, 2008, 1778(1), 242-249.
50. Cai, S.; Vijayan, K.; Cheng, D.; Lima, E.M.; Discher, D.E. Micelles of different morphologies-advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery. Pharm. Res., 2007, 24(11), 2099-2109. (Pubitemid 47493571)
51. Gobbi, M.; Re, F.; Canovi, M.; Beeg, M.; Gregori, M.; Sesana, S.; Sonnino, S.; Brogioli, D.; Musicanti, C.; Gasco, P.; Salmona, M.; Masserini, M.E. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. Biomaterials, 2010, 31(25), 6519-6529.
52. Duncan, R. Polymer-drug conjugates: Targeting cancer, in Biomedical aspects of drug targeting, Muzykantov, V. T., editor; Kluwer Academic Publishers: Boston, 2003; pp. 193-209.
53. Saad, M.; Garbuzenko, O.B.; Ber, E.; Chandna, P.; Khandare, J.J.; Pozharov, V.P.; Minko, T. Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumorspecific treatment and imaging? J. Controlled Release, 2008, 130(2), 107-114.
54. Champion, J.A.; Walker, A.; Mitragotri, S. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res., 2008, 25(8), 1815-1821.
55. Decuzzi, P.; Godin, B.; Tanaka, T.; Lee, S.Y.; Chiappini, C.; Liu, X.; Ferrari, M. Size and shape effects in the biodistribution of intravascularly injected particles. J. Controlled Release, 2010, 141(3), 320-327.
56. Simone, E.; Ding, B.S.; Muzykantov, V. Targeted delivery of therapeutics to endothelium. Cell Tissue Res., 2009, 335(1), 283-300.
57. Arap, W.; Pasqualini, R.; Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 1998, 279(5349), 377-380. (Pubitemid 28063372)
58. Shelley, S.A. Nanobiotechnology cancer's newest deadly foe. Chem. Eng. Progr., 2006, 102(2), 43-48.
59. Mainardes, R.M.; Silva, L.P. Drug delivery systems: Past, present, and future. Curr. Drug Targets, 2004, 5(5), 449-455. (Pubitemid 38807819)
60. Moghimi, S.M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res., 2003, 42(6), 463-478. (Pubitemid 37237636)
61. Whitesides, G.M. The 'right' size in nanobiotechnology. Nat. Biotechnol., 2003, 21(10), 1161-1165. (Pubitemid 37186172)
62. Pardridge, W.M. Molecular Trojan horses for blood-brain barrier drug delivery. Curr. Opin. Pharmacol., 2006, 6(5), 494-500. (Pubitemid 44348531)
63. Schnitzer, J.E. Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deliv. Rev., 2001, 49(3), 265-280. (Pubitemid 32718688)
64. Wiewrodt, R.; Thomas, A.P.; Cipelletti, L.; Christofidou-Solomidou, M.; Weitz, D.A.; Feinstein, S.I.; Schaffer, D.; Albelda, S.M.; Koval, M.; Muzykantov, V.R. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood, 2002, 99(3), 912-922. (Pubitemid 34525553)
65. Squire, J.M.; Chew, M.; Nneji, G.; Neal, C.; Barry, J.; Michel, C. Quasi-periodic substructure in the microvessel endothelial glycocalyx: A possible explanation for molecular filtering? J. Struct. Biol., 2001, 136(3), 239-255.
66. Champion, J.A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA, 2006, 103(13), 4930-4934.
67. Huang, R.B.; Mocherla, S.; Heslinga, M.J.; Charoenphol, P.; Eniola-Adefeso, O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Mol. Membr. Biol., 2010, 27(4-6), 190-205.
68. Mulivor, A.W.; Lipowsky, H.H. Role of glycocalyx in leukocyteendothelial cell adhesion. Am. J. Physiol. Heart. Circ. Physiol., 2002, 283(4), H1282-H1291.
69. Weinbaum, S.; Zhang, X.; Han, Y.; Vink, H.; Cowin, S.C. Mechanotransduction and flow across the endothelial glycocalyx. Proc. Natl. Acad. Sci. USA, 2003, 100(13), 7988-7995. (Pubitemid 36760082)
70. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA, 2008, 105(38), 14265-14270.
71. Lynch, I.; Cedervall, T.; Lundqvist, M.; Cabaleiro-Lago, C.; Linse, S.; Dawson, K.A. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci., 2007, 134-135 167-174. (Pubitemid 47614904)
72. Lynch, I.; Salvati, A.; Dawson, K.A. Protein-nanoparticle interactions: What does the cell see? Nat. Nanotechnol., 2009, 4(9), 546-547.
73. Vasir, J.K.; Labhasetwar, V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials, 2008, 29(31), 4244-4252.
74. Mehta, D.; Malik, A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev., 2006, 86(1), 279-367.
75. Hong, S.; Leroueil, P.R.; Majoros, I.J.; Orr, B.G.; Baker, J.R., Jr.; Banaszak Holl, M.M. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol., 2007, 14(1), 107-115. (Pubitemid 46124068)
76. Kaittanis, C.; Santra, S.; Perez, J.M. Emerging nanotechnologybased strategies for the identification of microbial pathogenesis. Adv. Drug Deliv. Rev., 2010, 62(4-5), 408-423.
77. Kaittanis, C.; Santra, S.; Perez, J.M. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J. Am. Chem. Soc., 2009, 131(35), 12780-12791.
78. Basha, S.; Rai, P.; Poon, V.; Saraph, A.; Gujraty, K.; Go, M.Y.; Sadacharan, S.; Frost, M.; Mogridge, J.; Kane, R.S. Polyvalent inhibitors of anthrax toxin that target host receptors. Proc. Natl. Acad. Sci. USA, 2006, 103(36), 13509-13513. (Pubitemid 44380138)
79. Rai, P.; Padala, C.; Poon, V.; Saraph, A.; Basha, S.; Kate, S.; Tao, K.; Mogridge, J.; Kane, R.S. Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins. Nat. Biotechnol., 2006, 24(5), 582-586.
80. Decuzzi, P.; Pasqualini, R.; Arap, W.; Ferrari, M. Intravascular delivery of particulate systems: Does geometry really matter? Pharm. Res., 2009, 26(1), 235-243.
81. Atochina, E.N.; Balyasnikova, I.V.; Danilov, S.M.; Granger, D.N.; Fisher, A.B.; Muzykantov, V.R. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am. J. Physiol., 1998, 275(4 Pt 1), L806-L817.
82. Ding, B.S.; Gottstein, C.; Grunow, A.; Kuo, A.; Ganguly, K.; Albelda, S.M.; Cines, D.B.; Muzykantov, V.R. Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. Blood, 2005, 106(13), 4191-4198. (Pubitemid 41775926)
83. Gosk, S.; Moos, T.; Gottstein, C.; Bendas, G. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim. Biophys. Acta, 2008, 1778(4), 854-863.
84. Luo, G.X.; Kohlstaedt, L.A.; Charles, C.H.; Gorfain, E.; Morantte, I.; Williams, J.H.; Fang, F. Humanization of an anti-ICAM-1 antibody with over 50-fold affinity and functional improvement. J. Immunol. Methods, 2003, 275(1-2), 31-40. (Pubitemid 36351540)
85. Marlin, S.D.; Springer, T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell, 1987, 51(5), 813-819.
86. Jevnikar, A.M.; Wuthrich, R.P.; Takei, F.; Xu, H.W.; Brennan, D.C.; Glimcher, L.H.; Rubin-Kelley, V.E. Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kidney Int., 1990, 38(3), 417-425. (Pubitemid 20258743)
87. Kiani, M.F.; Yuan, H.; Chen, X.; Smith, L.; Gaber, M.W.; Goetz, D.J. Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules. Pharm. Res., 2002, 19(9), 1317-1322.
88. Doshi, N.; Prabhakarpandian, B.; Rea-Ramsey, A.; Pant, K.; Sundaram, S.; Mitragotri, S. Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networks. J. Controlled Release, 2010, 146(2), 196-200.
89. Liu, J.; Weller, G.E.R.; Zern, B.; Ayyaswamy, P.S.; Eckmann, D.M.; Muzykantov, V.R.; Radhakrishnan, R. A computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and Atomic Force Microscopy experiments. Proc. Natl. Acad. Sci. USA, 2010, 107(38), 16530-16535.
90. Bevilacqua, M.P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol., 1993, 11:767-804, 1993. -804. (Pubitemid 23115023)
91. Bloemen, P.G.; Henricks, P.A.; van Bloois, L.; van den Tweel, M.C.; Bloem, A.C.; Nijkamp, F.P.; Crommelin, D.J.; Storm, G. Adhesion molecules: A new target for immunoliposome-mediated drug delivery. FEBS Lett., 1995, 357(2), 140-144.
92. Muro, S.; Muzykantov, V.R. Targeting of antioxidant and antithrombotic drugs to endothelial cell adhesion molecules. Curr. Pharm. Des., 2005, 11(18), 2383-2401. (Pubitemid 40872703)
93. Newman, P.J.; Albelda, S.M. Cellular and molecular aspects of PECAM-1. Nouv. Rev. Fr. Hematol. , 1992, 34(S), 9-13.
94. McIntosh, D.P.; Tan, X.Y.; Oh, P.; Schnitzer, J.E. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: A pathway to overcome cell barriers to drug and gene delivery. Proc. Natl. Acad. Sci. USA, 2002, 99(4), 1996-2001. (Pubitemid 34169003)
95. Jefferies, W.A.; Brandon, M.R.; Hunt, S.V.; Williams, A.F.; Gatter, K.C.; Mason, D.Y. Transferrin receptor on endothelium of brain capillaries. Nature, 1984, 312(5990), 162-163. (Pubitemid 14000081)
96. Soda, R.; Tavassoli, M. Liver endothelium and not hepatocytes or Kupffer cells have transferrin receptors. Blood, 1984, 63(2), 270-276. (Pubitemid 14188870)
97. Kozower, B.D.; Christofidou-Solomidou, M.; Sweitzer, T.D.; Muro, S.; Buerk, D.G.; Solomides, C.C.; Albelda, S.M.; Patterson, G.A.; Muzykantov, V.R. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol., 2003, 21(4), 392-398. (Pubitemid 36397659)
98. Muro, S.; Cui, X.M.; Gajewski, C.; Murciano, J.C.; Muzykantov, V.R.; Koval, M. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am. J. Physiol. Cell Physiol., 2003, 285(5), C1339-C1347. (Pubitemid 37296311)
99. Albelda, S.M. Endothelial and epithelial-cell adhesion molecules. Am. J. Respir. Cell Mol. Biol., 1991, 4(3), 195-203.
100. Kumasaka, T.; Quinlan, W.M.; Doyle, N.A.; Condon, T.P.; Sligh, J.; Takei, F.; Beaudet, A.L.; Bennett, C.F.; Doerschuk, C.M. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxininduced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest., 1996, 97(10), 2362-2369.
101. Kishimoto, T. K.; Rothlein, R. Integrins, ICAMs, and Selectins: Role and Regulation of Adhesion Molecules in Neutrophil Recruitment to Inflammatory Sites, in Advances in Pharmacology, Volume 25 ed.; August, J. T., editor; Academic Press: 1994; pp. 117-169.
102. Almenar-Queralt, A.; Duperray, A.; Miles, L.A.; Felez, J.; Altieri, D.C. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am. J. Pathol., 1995, 147(5), 1278-1288.
103. Christofidou-Solomidou, M.; Kennel, S.; Scherpereel, A.; Wiewrodt, R.; Solomides, C.C.; Pietra, G.G.; Murciano, J.C.; Shah, S.A.; Ischiropoulos, H.; Albelda, S.M.; Muzykantov, V.R. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: Targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration. Am. J. Pathol., 2002, 160(3), 1155-1169. (Pubitemid 34224601)
104. Takei, Y.; Nishimura, Y.; Kawano, S.; Nagai, H.; Ohmae, A.; Fusamoto, H.; Kamada, T. Expression of ICAM-1 is involved in the mechanism of liver injury during liver transplantation: Therapeutic usefulness of the F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody. Transplant. Proc., 1996, 28(2), 1103-1105. (Pubitemid 26138543)
105. Villanueva, F.S.; Jankowski, R.J.; Klibanov, S.; Pina, M.L.; Alber, S.M.; Watkins, S.C.; Brandenburger, G.H.; Wagner, W.R. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation, 1998, 98(1), 1-5. (Pubitemid 28312070)
106. Weiner, R.E.; Sasso, D.E.; Gionfriddo, M.A.; Thrall, R.S.; Syrbu, S.; Smilowitz, H.M.; Vento, J. Early detection of oleic acidinduced lung injury in rats using (111) In-labeled anti-rat intercellular adhesion molecule-1. J. Nucl. Med., 2001, 42(7), 1109-1115. (Pubitemid 32595312)
107. Weller, G.E.; Villanueva, F.S.; Klibanov, A.L.; Wagner, W.R. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann. Biomed. Eng., 2002, 30(8), 1012-1019. (Pubitemid 35457697)
108. Aarts, P.A.; van den Broek, S.A.; Prins, G.W.; Kuiken, G.D.; Sixma, J.J.; Heethaar, R.M. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis, 1988, 8(6), 819-824. (Pubitemid 19005370)
109. Agarwal, P.K.; Billeter, S.R.; Rajagopalan, P.T.; Benkovic, S.J.; Hammes-Schiffer, S. Network of coupled promoting motions in enzyme catalysis. Proc. Natl. Acad. Sci. USA, 2002, 99(5), 2794-2799. (Pubitemid 34240540)
110. Muro, S. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1, in Endothelial Biomedicine, Aird, W. C., editor; Cambridge University Press: New York, 2007; Chapter 117, pp. 1058-1070.
111. Worthylake, R.A.; Burridge, K. Leukocyte transendothelial migration: Orchestrating the underlying molecular machinery. Curr. Opin. Cell Biol., 2001, 13(5), 569-577. (Pubitemid 32817015)
112. Agarwal, P.K.; Geist, A.; Gorin, A. Protein dynamics and enzymatic catalysis: Investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A. Biochemistry (Mosc)., 2004, 43(33), 10605-10618. (Pubitemid 39096703)
113. Davies, P.F. NO flow helps clear murky waters. Circ. Res., 1996, 78(5), 945-946.
114. Gan, H.H.; Perlow, R.A.; Roy, S.; Ko, J.; Wu, M.; Huang, J.; Yan, S.; Nicoletta, A.; Vafai, J.; Sun, D.; Wang, L.; Noah, J.E.; Pasquali, S.; Schlick, T. Analysis of protein sequence/structure similarity relationships. Biophys. J., 2002, 83(5), 2781-2791. (Pubitemid 35265769)
115. Tzima, E.; Del Pozo, M.A.; Kiosses, W.B.; Mohamed, S.A.; Li, S.; Chien, S.; Schwartz, M.A. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J., 2002, 21(24), 6791-6800. (Pubitemid 36014551)
116. Wei, Z.; Costa, K.; Al Mehdi, A.B.; Dodia, C.; Muzykantov, V.; Fisher, A.B. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ. Res., 1999, 85(8), 682-689. (Pubitemid 29480808)
117. Sun, R.J.; Muller, S.; Stoltz, J.F.; Wang, X. Shear stress induces caveolin-1 translocation in cultured endothelial cells. Eur. Biophys. J., 2002, 30(8), 605-611. (Pubitemid 34168784)
118. Eniola, A.O.; Rodgers, S.D.; Hammer, D.A. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials, 2002, 23(10), 2167-2177. (Pubitemid 34226577)
119. Hallahan, D.E.; Virudachalam, S. Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc. Natl. Acad. Sci. USA, 1997, 94(12), 6432-6437. (Pubitemid 27270702)
120. Hopkins, A.M.; Baird, A.W.; Nusrat, A. ICAM-1: Targeted docking for exogenous as well as endogenous ligands. Adv. Drug Deliv. Rev., 2004, 56(6), 763-778. (Pubitemid 38520098)
121. Kim, D.W.; Langille, B.L.; Wong, M.K.; Gotlieb, A.I. Patterns of endothelial microfilament distribution in the rabbit aorta in situ. Circ. Res., 1989, 64(1), 21-31. (Pubitemid 19028500)
122. Davies, P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev., 1995, 75(3), 519-560.
123. Ho, K.; Lapitsky, Y.; Shi, M.; Shoichet, M. Tunable immunonanoparticle binding to cancer cells: Thermodynamic analysis of targeted drug delivery vehicles. Soft Matter, 2009, 5 1074-1080.
124. Agrawal, N.J.; Radhakrishnan, R. Role of glycocalyx in nanocarrier-cell adhesion: Thermodynamic model and Monte Carlo simulations. J. Phys. Chem. B, 2007, 111(43), 15848-15856. (Pubitemid 350097650)
125. Mulivor, A.W.; Lipowsky, H.H. Inflammation-and ischemiainduced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol., 2004, 286(5), H1672-H1680. (Pubitemid 38525453)
126. Chappell, D.; Dorfler, N.; Jacob, M.; Rehm, M.; Welsch, U.; Conzen, P.; Becker, B.F. Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock, 2010, 34(2), 133-139.
127. Damiano, E.R. The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries. Microvasc. Res., 1998, 55(1), 77-91. (Pubitemid 28368415)
128. Potter, D.R.; Damiano, E.R. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ. Res., 2008, 102(7), 770-776. (Pubitemid 351521584)
129. Potter, D.R.; Jiang, J.; Damiano, E.R. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ. Res., 2009, 104(11), 1318-1325.
130. Vink, H.; Duling, B.R. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am. J. Physiol. Heart. Circ. Physiol., 2000, 278(1), H285-H289. (Pubitemid 30101882)
131. Pries, A.R.; Secomb, T.W.; Gaehtgens, P. The endothelial surface layer. Pflugers Arch, 2000, 440(5), 653-666.
132. Grest, G. S. Normal and shear forces between polymer brushes, in Polymers in Confined Environments, Granick, S., editor; Springer-Verlag: Berlin, 1999; Vol. 138, pp. 149-183.
133. Klein, J. Reduction of frictional forces between solid-surfaces bearing polymer brushes. Nature, 1994, 370 634-636. (Pubitemid 24270679)
134. Milner, S.T. Hydrodynamic penetration into parabolic brushes. Macromolecules, 1991, 24(12) 3704-3705. (Pubitemid 21650163)
135. Guo, P.; Weinstein, A.M.; Weinbaum, S. A hydrodynamic mechanosensory hypothesis for brush border microvilli. Am. J. Physiol. Renal Physiol., 2000, 279(4), F698-F712.
136. Bhatia, S.K.; King, M.R.; Hammer, D.A. The state diagram for cell adhesion mediated by two receptors. Biophys. J., 2003, 84(4), 2671-2690. (Pubitemid 36373588)
137. Hanley, W.; McCarty, O.; Jadhav, S.; Tseng, Y.; Wirtz, D.; Konstantopoulos, K. Single molecule characterization of Pselectin/ ligand binding. J. Biol. Chem., 2003, 278(12), 10556-10561. (Pubitemid 36800324)
138. Bell, G.I.; Dembo, M.; Bongrand, P. Cell adhesion. Competition between nonspecific repulsion and specific bonding. Biophys. J., 1984, 45(6), 1051-1064. (Pubitemid 14099481)
139. Bell, G.I. Models for the specific adhesion of cells to cells. Science, 1978, 200(4342), 618-627.
140. Dobrowsky, T.M.; Daniels, B.R.; Siliciano, R.F.; Sun, S.X.; Wirtz, D. Organization of cellular receptors into a nanoscale junction during HIV-1 adhesion. PLOS Comp. Biol., 2010, 6(7), e1000855.
141. Decuzzi, P.; Gentile, F.; Granaldi, A.; Curcio, A.; Causa, F.; Indolfi, C.; Netti, P.; Ferrari, M. Flow chamber analysis of size effects in the adhesion of spherical particles. Int. J. Nanomedicine, 2007, 2(4), 689-696.
142. Decuzzi, P.; Ferrari, M. The receptor-mediated endocytosis of nonspherical particles. Biophys. J., 2008, 94(10), 3790-3797.
143. Lee, S.Y.; Ferrari, M.; Decuzzi, P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology, 2009, 20(49), 495101.
144. Beste, M.T.; Hammer, D.A. Selectin catch-slip kinetics encode shear threshold adhesive behavior of rolling leukocytes. Proc. Natl. Acad. Sci. USA, 2008, 105(52), 20716-20721.
145. Muro, S.; Muzykantov, V.R.; Murciano, J.C. Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals. Methods Mol. Biol., 2004, 283 21-36.
146. Cardena, E. Evaluation of post-traumatic stress disorders. Mil. Med., 2001, 166(12 Suppl), 53-54. (Pubitemid 34015259)
147. Malek, A.M.; Gibbons, G.H.; Dzau, V.J.; Izumo, S. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J. Clin. Invest., 1993, 92(4), 2013-2021. (Pubitemid 23304572)
148. Al Mehdi, A.B.; Zhao, G.; Dodia, C.; Tozawa, K.; Costa, K.; Muzykantov, V.; Ross, C.; Blecha, F.; Dinauer, M.; Fisher, A.B. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ. Res., 1998, 83(7), 730-737. (Pubitemid 28462787)
149. Muro, S.; Wiewrodt, R.; Thomas, A.; Koniaris, L.; Albelda, S.M.; Muzykantov, V.R.; Koval, M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci., 2003, 116(Pt 8), 1599-1609. (Pubitemid 36527505)